z-logo
Premium
Inside Cover: Spectroscopic and Computational Investigations of Ligand Binding to IspH: Discovery of Non‐diphosphate Inhibitors (ChemBioChem 10/2017)
Author(s) -
O'Dowd Bing,
Williams Sarah,
Wang Hongxin,
No Joo Hwan,
Rao Guodong,
Wang Weixue,
McCammon J. Andrew,
Cramer Stephen P.,
Oldfield Eric
Publication year - 2017
Publication title -
chembiochem
Language(s) - English
Resource type - Reports
SCImago Journal Rank - 1.05
H-Index - 126
eISSN - 1439-7633
pISSN - 1439-4227
DOI - 10.1002/cbic.201700218
Subject(s) - in silico , ligand (biochemistry) , chemistry , enzyme , stereochemistry , biosynthesis , drug discovery , drug target , terpenoid , biochemistry , computational biology , biology , receptor , gene
The inside cover picture shows the structure of the isoprenoid biosynthesis enzyme IspH with a newly discovered drug‐like inhibitor, a lipophilic barbiturate. IspH catalyzes the formation of ( E )‐1‐hydroxy‐2‐methylbut‐2‐enyl 4‐diphosphate, an essential enzyme in isoprenoid biosynthesis in most bacteria, malaria parasites, and plants. The results of spectroscopic studies (including HYSCORE and NRVS) led to a general model for ligand binding to IspH in which ligands bind directly to, or near to, the unique fourth Fe in the 4 Fe−4 S cluster. In silico screening of compound libraries led to new IspH inhibitors with ∼500 n m activity, potential leads for anti‐infectives and herbicides. More information can be found in the communication by E. Oldfield et al. on page 914 in Issue 10, 2017 (DOI: 10.1002/cbic.201700052).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom